Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02788214 · ClinicalTrials.gov registry record
Helicobacter Pylori Genome Project (HpGP)
A clinical trial, sponsored by National Cancer Institute (NCI).
- Terminated
- Registry status
- 1,000
- Enrollment target
NCT02788214: Clinical Trial study, sponsored by National Cancer Institute (NCI).
NCT02788214 is a clinical trial that was terminated before completion, run by National Cancer Institute (NCI). The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02788214 was terminated before completion, sponsored by National Cancer Institute (NCI).
- TERMINATED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
Helicobacter pylori is a common bacterial infection. It can lead to severe stomach problems, including stomach cancer. Researchers want to look at samples of the bacteria. These H. pylori strains will be taken from chronically infected people. They want to identify the genetic and epigenetic differences in H. pylori strains. This could help predict which people who get infected with the bacteria will get stomach cancer. This could lead to the cancer being detected earlier. It could also mean less people get stomach cancer. Objectives: To study genetic variations of H. pylori strains based on samples from chronically infected people. To identify the features of strains that might lead to severe stomach problems or stomach cancer. Eligibility: People ages 30-70 years who need an upper endoscopy or who were recently diagnosed with stomach cancer Design: Participants will be screened by the doctor who does their procedure and a study nurse. Participants who have endoscopy will have \~6 biopsies removed. These are tissue samples. They are about the size of a grain of rice. Participants will allow the study team to access reports from their stomach exam. Participants with stomach cancer will donate some of the tissue that will be removed during their clinical care. They will allow the study team to access reports of their surgery. They will also allow them to access the microscope slides of their stomach.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2016-07-27 |
| Est. Completion | 2020-05-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02788214
The ClinicalTrials.gov registry entry for NCT02788214 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02788214 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02788214 about?
NCT02788214 is a clinical study titled "Helicobacter Pylori Genome Project (HpGP)". Helicobacter pylori is a common bacterial infection. It can lead to severe stomach problems, including stomach cancer. Researchers want to look at samples of the bacteria. These H. pylori strains will be taken from chronically infected people. They want to identify the genetic and epigenetic differe...
What is the current status of trial NCT02788214?
This trial is currently terminated. The enrollment target is 1,000 participants. The study started on 2016-07-27. Estimated completion is 2020-05-15.
Who is sponsoring clinical trial NCT02788214?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.